Literature DB >> 8979770

Involvement of biogenic amines and amino acids in the central regulation of cardiovascular homeostasis.

N Singewald1, A Philippu.   

Abstract

Biogenic amines and amino acids have been implicated in central cardiovascular homeostasis. Initially, drugs were injected into the brain and their effects on blood pressure were investigated. Other approaches allowed endogenous neurotransmitters released in the extracellular space of brain structures involved in cardiovascular regulation to be identified. As Nicolas Singewald and Athineos Philippu outline, even slight disturbances in blood pressure and/or isovolaemia lead to marked changes in the release rates of biogenic amines and amino acids in various brain structures. Blood pressure homeostasis is maintained with the participation of several brain regions and neurotransmitters which possess the same or opposing functions when released from CNS neurones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8979770

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  12 in total

1.  Modulation of the baroreceptor reflex by alpha 2A-adrenoceptors: a study in alpha 2A knockout mice.

Authors:  Nathalie Niederhoffer; Lutz Hein; Klaus Starke
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

2.  Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis.

Authors:  Begoña Fernández-Pastor; Yolanda Mateo; Sonia Gómez-Urquijo; J Javier Meana
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

3.  Biogenic amines serotonin and dopamine regulate cholangiocyte hyperplastic and neoplastic growth.

Authors:  Gabriel A Frampton; Huang Li; Jonathan Ramirez; Akimuddin Mohamad; Sharon Demorrow
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

Review 4.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

5.  Ionotropic glutamate receptors in hypothalamic paraventricular and supraoptic nuclei mediate vasopressin and oxytocin release in unanesthetized rats.

Authors:  Cristiane Busnardo; Carlos C Crestani; Leonardo B M Resstel; Rodrigo F Tavares; José Antunes-Rodrigues; Fernando M A Corrêa
Journal:  Endocrinology       Date:  2012-03-06       Impact factor: 4.736

6.  Differential amino acid transmission in the locus coeruleus of Wistar Kyoto and spontaneously hypertensive rats.

Authors:  S T Kaehler; P Salchner; N Singewald; A Philippu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-23       Impact factor: 3.000

7.  The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.

Authors:  Antti Haapalinna; Tiina Leino; Esa Heinonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

8.  Involvement of the sympathetic nervous system in the reversal of critical haemorrhagic hypotension by endogenous central histamine in rats.

Authors:  Jerzy Jochem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-28       Impact factor: 3.000

9.  Subcellular localization of the antidepressant-sensitive norepinephrine transporter.

Authors:  Heinrich J G Matthies; Qiao Han; Angela Shields; Jane Wright; Jessica L Moore; Danny G Winder; Aurelio Galli; Randy D Blakely
Journal:  BMC Neurosci       Date:  2009-06-23       Impact factor: 3.288

10.  Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.

Authors:  Daniela Kuzdas; Sylvia Stemberger; Stefano Gaburro; Nadia Stefanova; Nicolas Singewald; Gregor K Wenning
Journal:  Exp Neurol       Date:  2013-02-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.